Resultados da busca - Han-Zhang, Han
- Mostrando 1 - 20 resultados de 38
- Ir para a próxima página
-
1
The prevalence and prognostic value of KRAS co‐mutation subtypes in Chinese advanced non‐small cell lung cancer patients por Cai, Dongjing, Hu, Chengping, Li, Li, Deng, Shichao, Yang, Jing, Han‐Zhang, Han, Li, Min
Publicado em 2019Texto -
2
An EGFR-Amplified Cervical Squamous Cell Carcinoma Patient with Pulmonary Metastasis Benefits from Afatinib: A Case Report por Chen, Qian, Huang, Yihua, Shao, Lin, Han-Zhang, Han, Yang, Fan, Wang, Yang, Liu, Jing, Gan, Jiadi
Publicado em 2020Texto -
3
Efficacy of afatinib in a HER2 amplification-positive endometrioid adenocarcinoma patient– a case report por Zhou, Li, Ren, Yifeng, Wang, Xia, Miao, Dongliu, Lizaso, Analyn, Li, Haiyan, Han-Zhang, Han, Qian, Jun, Yang, Hui
Publicado em 2019Texto -
4
Exceptional Response of Cryoablation Followed by Pembrolizumab in a Patient with Metastatic Cervical Carcinosarcoma with High Tumor Mutational Burden: A Case Report por Zhu, Baorang, Liu, Ying, Li, Jing, Diao, Liyan, Shao, Lin, Han‐Zhang, Han, Zhang, Lu, Kang, Qiaolin, Yang, Wuwei
Publicado em 2019Texto -
5
Perioperative Circulating Tumor DNA in Colorectal Liver Metastases: Concordance with Metastatic Tissue and Predictive Value for Tumor Burden and Prognosis por He, Yiping, Ma, Xiaoji, Chen, Ke, Liu, Fangqi, Cai, Sanjun, Han-Zhang, Han, Hou, Ting, Xiang, Jianxing, Peng, Junjie
Publicado em 2020Texto -
6
Clinicopathologic features and genomic analysis of pulmonary blastomatoid carcinosarcoma por Zhao, Jikai, Xiang, Chan, Zhao, Ruiying, Guo, Ping, Zheng, Jingjing, Han-Zhang, Han, Yu, Keke, Zhang, Jie, Han, Yuchen
Publicado em 2020Texto -
7
Maximum allele frequency observed in plasma: A potential indicator of liquid biopsy sensitivity por Tang, Yong, Liu, Xianling, Ou, Zhu'An, He, Zhe, Zhu, Qihang, Wang, Ye, Yang, Mei, Ye, Junyi, Han-Zhang, Han, Qiao, Guibin
Publicado em 2019Texto -
8
The association between BRAF mutation class and clinical features in BRAF-mutant Chinese non-small cell lung cancer patients por Lin, Quan, Zhang, Haoran, Ding, Huaxin, Qian, Jun, Lizaso, Analyn, Lin, Jing, Han-Zhang, Han, Xiang, Jianxing, Li, Yuping, Zhu, Hong
Publicado em 2019Texto -
9
Somatic POLE exonuclease domain mutations elicit enhanced intratumoral immune responses in stage II colorectal cancer por Mo, Shaobo, Ma, Xiaoji, Li, Yaqi, Zhang, Long, Hou, Ting, Han-Zhang, Han, Qian, Juanjuan, Cai, Sanjun, Huang, Dan, Peng, Junjie
Publicado em 2020Texto -
10
Targeted Sequencing Analysis of Predominant Histological Subtypes in Resected Stage I Invasive Lung Adenocarcinoma por Li, Yan, Tan, Yan, Hu, Song, Xie, Jun, Yan, Zhantao, Zhang, Xian, Zong, Yun, Han-Zhang, Han, Li, Qing, Li, Chong
Publicado em 2021Texto -
11
IBI362 (LY3305677), a weekly-dose GLP-1 and glucagon receptor dual agonist, in Chinese adults with overweight or obesity: A randomised, placebo-controlled, multiple ascending dose... por Ji, Linong, Jiang, Hongwei, An, Pei, Deng, Huan, Liu, Meng, Li, Li, Feng, Liqi, Song, Baili, Han-Zhang, Han, Ma, Qingyang, Qian, Lei
Publicado em 2021Texto -
12
Comparison of genomic landscapes of large cell neuroendocrine carcinoma, small cell lung carcinoma, and large cell carcinoma por Zhou, Zhen, Zhu, Lei, Niu, Xiaomin, Shen, Shengping, Zhao, Yi, Zhang, Jie, Ye, Junyi, Han‐Zhang, Han, Liu, Junjun, Liu, Chenglin, Lu, Shun
Publicado em 2019Texto -
13
Parallel serial assessment of somatic mutation and methylation profile from circulating tumor DNA predicts treatment response and impending disease progression in osimertinib-treat... por Xia, Shu, Ye, Junyi, Chen, Yu, Lizaso, Analyn, Huang, Le, Shi, Lei, Su, Jing, Han-Zhang, Han, Chuai, Shannon, Li, Lingling, Chen, Yuan
Publicado em 2019Texto -
14
Distinctive genomic characteristics in POLE/POLD1-mutant cancers can potentially predict beneficial clinical outcomes in patients who receive immune checkpoint inhibitor por He, Junjun, Ouyang, Wei, Zhao, Wugan, Shao, Lin, Li, Bing, Liu, Bihao, Wang, Dejuan, Han-Zhang, Han, Zhang, Zhou, Shao, Liang, Li, Wencai
Publicado em 2021Texto -
15
Efficacy of erlotinib as neoadjuvant regimen in EGFR-mutant locally advanced non-small cell lung cancer patients por Xiong, Liwen, Lou, Yuqing, Bai, Hao, Li, Rong, Xia, Jinjing, Fang, Wentao, Zhang, Jie, Han-Zhang, Han, Lizaso, Analyn, Li, Bing, Gu, Aiqin, Han, Baohui
Publicado em 2019Texto -
16
Liquid biopsy in extranodal NK/T-cell lymphoma: a prospective analysis of cell-free DNA genotyping and monitoring por Qi, Fei, Cao, Zheng, Chen, Bo, Chai, Yue, Lin, Jing, Ye, Junyi, Wei, Yuce, Liu, Hao, Han-Zhang, Han, Mao, Xinru, Feng, Xiaoli, Dong, Mei
Publicado em 2021Texto -
17
Mutational landscape and clonal diversity of pulmonary adenoid cystic carcinoma por Li, Min, Zhao, Bing-Rong, Liu, Shi-Qing, An, Jian, Deng, Peng-Bo, Han-Zhang, Han, Ye, Jun-Yi, Mao, Xin-Ru, Chuai, Shao-Kun, Hu, Cheng-Ping
Publicado em 2018Texto -
18
Characterization of Frequently Mutated Cancer Genes and Tumor Mutation Burden in Chinese Breast Cancer por Xiao, Weikai, Zhang, Guochun, Chen, Bo, Chen, Xiaoqing, Wen, Lingzhu, Lai, Jianguo, Li, Xuerui, Li, Min, Liu, Hao, Liu, Jing, Han-Zhang, Han, Lizaso, Analyn, Liao, Ning
Publicado em 2021Texto -
19
Mutational Landscape of PI3K-AKT-mTOR Pathway in Breast Cancer: Implications for Targeted Therapeutics por Xiao, Weikai, Zhang, Guochun, Chen, Bo, Chen, Xiaoqing, Wen, Lingzhu, Lai, Jianguo, Li, Xuerui, Li, Min, Liu, Hao, Liu, Jing, Han-Zhang, Han, Lizaso, Analyn, Liao, Ning
Publicado em 2021Texto -
20
A phase 1b randomised controlled trial of a glucagon-like peptide-1 and glucagon receptor dual agonist IBI362 (LY3305677) in Chinese patients with type 2 diabetes por Jiang, Hongwei, Pang, Shuguang, Zhang, Yawei, Yu, Ting, Liu, Meng, Deng, Huan, Li, Li, Feng, Liqi, Song, Baili, Han-Zhang, Han, Ma, Qingyang, Qian, Lei, Yang, Wenying
Publicado em 2022Texto